AJP - Lung AJP: Lung Cellular and Molecular Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 278: L988-L999, 2000;
1040-0605/00 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (25)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Panoskaltsis-Mortari, A.
Right arrow Articles by Blazar, B. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Panoskaltsis-Mortari, A.
Right arrow Articles by Blazar, B. R.
Vol. 278, Issue 5, L988-L999, May 2000

KGF pretreatment decreases B7 and granzyme B expression and hastens repair in lungs of mice after allogeneic BMT

Angela Panoskaltsis-Mortari1, David H. Ingbar2, Patricia Jung2, Imad Y. Haddad2, Peter B. Bitterman2, O. Douglas Wangensteen3, Catherine L. Farrell4, David L. Lacey4, and Bruce R. Blazar1

1 Department of Pediatrics, Division of Hematology-Oncology and Bone Marrow Transplantation, and Departments of 2 Pulmonary Critical Care Medicine and 3 Physiology, University of Minnesota, Minneapolis, Minnesota 55455; and 4 Amgen, Thousand Oaks, California 91320

We investigated keratinocyte growth factor (KGF) as a pretreatment therapy for idiopathic pneumonia syndrome (IPS) generated as a result of lung damage and allogeneic T cell-dependent inflammatory events occurring in the early peri-bone marrow (BM) transplant (BMT) period. B10.BR (H2k) recipient mice were transplanted with C57BL/6 (H2b) BM with spleen cells after lethal irradiation with and without cyclophosphamide conditioning with and without subcutaneous KGF pretreatment. KGF-pretreated mice had fewer injured alveolar type II (ATII) cells at the time of BMT and exhibited ATII cell hyperplasia at day 3 post-BMT. The composition of infiltrating cells on day 7 post-BMT was not altered by KGF pretreatment, but the frequencies of cells expressing the T-cell costimulatory molecules B7.1 and B7.2 and mRNA for the cytolysin granzyme B (usually increased in IPS) were decreased by KGF. Sera from KGF-treated mice had increases in the Th2 cytokines interleukin (IL)-4, IL-6, and IL-13 4 days after cessation of KGF administration (i.e., at the time of BMT). These data suggest that KGF hinders IPS by two modes: 1) stimulation of alveolar epithelialization and 2) attenuation of immune-mediated injury as a consequence of failure to upregulate cytolytic molecules and B7 ligand expression and the induction of anti-inflammatory Th2 cytokines in situ.

bone marrow transplant; keratinocyte growth factor; type II pneumocytes; cytokines; macrophages; costimulatory molecules


This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
A. Panoskaltsis-Mortari, K. V. Tram, A. P. Price, C. H. Wendt, and B. R. Blazar
A New Murine Model for Bronchiolitis Obliterans Post Bone Marrow Transplant
Am. J. Respir. Crit. Care Med., October 1, 2007; 176(7): 713 - 723.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Seggewiss, K. Lore, F. J. Guenaga, S. Pittaluga, J. Mattapallil, C. K. Chow, R. A. Koup, K. Camphausen, M. C. Nason, M. Meier-Schellersheim, et al.
Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaques.
Blood, July 1, 2007; 110(1): 441 - 449.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
N Blijlevens and S Sonis
Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis
Ann. Onc., May 1, 2007; 18(5): 817 - 826.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Panoskaltsis-Mortari, J. R. Hermanson, E. Taras, O. D. Wangensteen, I. F. Charo, B. J. Rollins, and B. R. Blazar
Post-BMT lung injury occurs independently of the expression of CCL2 or its receptor, CCR2, on host cells
Am J Physiol Lung Cell Mol Physiol, February 1, 2004; 286(2): L284 - L292.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
I. Y. Haddad, C. Milla, S. Yang, A. Panoskaltsis-Mortari, S. Hawgood, D. L. Lacey, and B. R. Blazar
Surfactant protein A is a required mediator of keratinocyte growth factor after experimental marrow transplantation
Am J Physiol Lung Cell Mol Physiol, September 1, 2003; 285(3): L602 - L610.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Panoskaltsis-Mortari, J. R. Hermanson, E. Taras, O. D. Wangensteen, J. S. Serody, and B. R. Blazar
Acceleration of idiopathic pneumonia syndrome (IPS) in the absence of donor MIP-1alpha (CCL3) after allogeneic BMT in mice
Blood, May 1, 2003; 101(9): 3714 - 3721.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
N. Dainiak, J. K. Waselenko, J. O. Armitage, T. J. MacVittie, and A. M. Farese
The Hematologist and Radiation Casualties
Hematology, January 1, 2003; 2003(1): 473 - 496.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Rossi, B. R. Blazar, C. L. Farrell, D. M. Danilenko, D. L. Lacey, K. I. Weinberg, W. Krenger, and G. A. Hollander
Keratinocyte growth factor preserves normal thymopoiesis and thymic microenvironment during experimental graft-versus-host disease
Blood, June 28, 2002; 100(2): 682 - 691.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
L. B. Ware and M. A. Matthay
Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair
Am J Physiol Lung Cell Mol Physiol, May 1, 2002; 282(5): L924 - L940.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
L. S. PRINCE, P. H. KARP, T. O. MONINGER, and M. J. WELSH
KGF alters gene expression in human airway epithelia: potential regulation of the inflammatory response
Physiol Genomics, July 17, 2001; 6(2): 81 - 89.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Panoskaltsis-Mortari, P. A. Taylor, J. S. Rubin, A. Uren, L. A. Welniak, W. J. Murphy, C. L. Farrell, D. L. Lacey, and B. R. Blazar
Keratinocyte growth factor facilitates alloengraftment and ameliorates graft-versus-host disease in mice by a mechanism independent of repair of conditioning-induced tissue injury
Blood, December 15, 2000; 96(13): 4350 - 4356.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. YANG, A. PANOSKALTSIS-MORTARI, D. H. INGBAR, S. MATALON, S. ZHU, E. R. RESNIK, C. L. FARRELL, D. L. LACEY, B. R. BLAZAR, and I. Y. HADDAD
Cyclophosphamide Prevents Systemic Keratinocyte Growth Factor-induced Up-Regulation of Surfactant Protein A after Allogeneic Transplant in Mice
Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1884 - 1890.
[Abstract] [Full Text]


Home page
BloodHome page
A. Panoskaltsis-Mortari, R. M. Strieter, J. R. Hermanson, K. V. Fegeding, W. J. Murphy, C. L. Farrell, D. L. Lacey, and B. R. Blazar
Induction of monocyte- and T-cell-attracting chemokines in the lung during the generation of idiopathic pneumonia syndrome following allogeneic murine bone marrow transplantation
Blood, August 1, 2000; 96(3): 834 - 839.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online